Eye Spy
Swati More, Ph.D, and Robert Vince, PhD., assess a patient using the noninvasive retina scan technology they developed

Finding a viable treatment for Alzheimer’s disease (AD) continues to frustrate researchers around the world. The University of Minnesota Center for Drug Design’s Robert Vince, PhD, and Swati More, PhD, aren’t exempt. Profs. Vince, More, and their colleagues are developing a drug to treat early AD, but they wanted a faster way to test whether their compound was working. So they created a cost-effective, noninvasive eye-scanning technology to do the job, and their breakthrough is commanding international attention. Read the full story by Barbara Knox